Detection of calf muscle alterations in patients with chronic heart failure by 31P magnetic resonance spectroscopy: Impaired adaptation to continuous exercise

Experimental and Clinical Cardiology

Volumn 10, Issue 1, 2005, Pages 4-8

  Nakae, Ichiro ^a   Mitsunami, Kenichi ^a   Matsuo, Shinro ^a   Inubushi, Toshiro ^a   Morikawa, Shigehiro ^a   Koh, Terue ^a   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

31P magnetic resonance spectroscopy; Calf muscle; Exercise tolerance; Heart failure

Indexed keywords

ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATINE PHOSPHATE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GE; HEMPA; PHOSPHATE;

ADULT; AGED; AORTA VALVE REGURGITATION; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; GASTROCNEMIUS MUSCLE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PLANTARIS MUSCLE; STATISTICAL SIGNIFICANCE;

EID: 18144398957     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation 1991;84:1597-607.
2. Drexler H, Riede U, Münzel T, Konig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85:1751-9.
3. Schaufelberger M, Andersson G, Eriksson BO, Grimby G, Held P, Swedberg K. Skeletal muscle changes in patients with chronic heart failure before and after treatment with enalapril. Eur Heart J 1996;17:1678-85.
4. Schaufelberger M, Eriksson BO, Grimby G, Held P, Swedberg K. Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J 1997;18:971-80.
5. Wilson JR, Fink L, Maris J, et al. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 1985;71:57-62.
6. Massie B, Conway M, Yonge R, et al. Skeletal muscle metabolism in patients with congestive heart failure: Relation to clinical severity and blood flow. Circulation 1987;76:1009-19.
7. 31P Nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 1987;60:309-15.
8. Massie BM, Conway M, Rajagopalan B, et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 1988;78:320-6.
9. Rajagopalan B, Conway MA, Massie B, Radda GK. Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure. Am J Cardiol 1988;62:53E-7E.
10. Mancini DM, Ferraro N, Tuchler M, Chance B, Wilson JR. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. Am J Cardiol 1988;62:1234-40.
11. 31P NMR spectroscopy. Evidence for impaired oxidative phosphorylation rate in skeletal muscle in patients with chronic heart failure. Eur Heart J 1998;19:124-31.
12. Harris RC, Edwards RH, Hultman E, Nordesjo LO, Nylind B, Sahlin K. The time course of phosphocreatine resynthesis during recovery of the quadriceps muscle in man. Pflugers Arch 1976;367:137-42.
13. Okita K, Nishijima H, Yonezawa K, et al. Skeletal muscle metabolism in maximal bicycle and treadmill exercise distinguished by using in vivo metabolic freeze method and phosphorus-31 magnetic resonance spectroscopy in normal men. Am J Cardiol 1998;81:106-9.
14. Okita K, Yonezawa K, Nishijima H, et al. Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure. Circulation 1998;98:1886-91.
15. 31P NMR spectroscopy. Magn Reson Imaging 1994; 12:1121-6.
16. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9.
17. Massie BM. Exercise tolerance in congestive heart failure. Role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment. Am J Med 1988;84:75-82.
18. Duscha BD, Kraus WE, Keteyian SJ, et al. Capillary density of skeletal muscle: A contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 1999;33:1956-63.
19. Harrington D, Coats AJ. Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure. Eur Heart J 1997;18:1865-72.
20. Meyer RA, Brown TR, Kushmerick MJ. Phosphorus nuclear resonance of fast- and slow-twitch muscle. Am J Physiol 1985;248:C279-87.
21. Lipkin DP, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) 1986;292:653-5.
22. Packer M, Gheorghiade M, Young JB, et al, for the RADIANCE Study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993;329:1-7.
23. Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996;110:325-32.
24. Opasich C, Pinna GD, Mazza A, et al. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J 2001;22:488-96.
25. Shah MR, Hasselblad V, Gheorghiade M, et al. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2001;88:987-93.
26. Taylor DJ, Crowe M, Bore PJ, Styles P, Arnold DL, Radda GK. Examination of the energetics of aging skeletal muscle using nuclear magnetic resonance. Gerontology 1984;30:2-7.
27. Mettauer B, Zoll J, Sanchez H, et al. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol 2001;38:947-54.
28. Duscha BD, Annex BH, Green HJ, Pippen AM, Kraus WE. Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol 2002;39:1170-4.
29. Minotti JR, Johnson EC, Hudson TL, et al. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 1990;86:751-8.
30. De Sousa E, Lechene P, Fortin D, et al. Cardiac and skeletal muscle energy metabolism in heart failure: Beneficial effects of voluntary activity. Cardiovasc Res 2002;56:260-8.
31. Vescovo G, Serafini F, Facchin L, et al. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: Differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 1996;76:337-43.
32. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 1996;79:128-36.
33. Bigard AX, Boehm E, Veksler V, Mateo P, Anflous K, Ventura-Clapier R. Muscle unloading induces slow to fast transitions in myofibrillar but not mitochondrial properties. Relevance to skeletal muscle abnormalities in heart failure. J Mol Cell Cardiol 1998;30:2391-401. (Erratum in 1999;31:927).
34. Nishiyama Y, Ikeda H, Haramaki N, Yoshida N, Imaizumi T. Oxidative stress is related to exercise intolerance in patients with heart failure. Am Heart J 1998;135:115-20.
35. Hambrecht R, Adams V, Gielen S, et al. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol 1999;33:174-9.